Stefania Pittaluga

45.4k citations

399 papers · 19.9k indexed · 3 hit papers · h-index 81

Impact in

Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment
Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 253
- Lymphoma Diagnosis and Treatment 244
Genetics 119
- Chronic Lymphocytic Leukemia Research 111

Co-authors: Elaine S. Jaffe Mark Raffeld Wyndham H. Wilson Seth M. Steinberg Kieron Dunleavy Louis M. Staudt Girish Venkataraman Richard F. Little
Journals: Blood (121 papers)The American Journal of Surgical Pathology (39 papers)Journal of Clinical Oncology (18 papers)Haematologica (14 papers)British Journal of Haematology (11 papers)
Partner nations: United States Belgium Germany

In The Last Decade

Stefania Pittaluga

388 papers receiving 19.5k citations

Hit Papers

align trajectories log scale

Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series 2020 · 373 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 EClinicalMedicine
2017 eLife
2013 Clinical Cancer Research

Peers

Countries citing papers authored by Stefania Pittaluga

Since Specialization

Citations

This map shows the geographic impact of Stefania Pittaluga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Pittaluga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Pittaluga more than expected).

Fields of papers citing papers by Stefania Pittaluga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Pittaluga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Pittaluga. The network helps show where Stefania Pittaluga may publish in the future.

Co-authors

The 25 scholars most cited alongside Stefania Pittaluga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stefania Pittaluga Line = papers co-authored together Stefania Pittaluga links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome Blood Advances ·Ramya Ramaswami, Kathryn Lurain, Mark N. Polizzotto, Kathline H. Kim, Irene Ekwede, Elena Tassi, Adam Rupert, Vickie Marshall, Mark J. Roth, Armando Filie, Stefania Pittaluga, Elaine S. Jaffe, Hao‐Wei Wang, Denise Whitby, Thomas S. Uldrick, Robert Yarchoan	2025	1
2	Resolution of Squamous-Cell Carcinoma by Restoring T-Cell Receptor Signaling New England Journal of Medicine ·Peiying Ye, Jenna Bergerson, Isaac Brownell, Gabriel J. Starrett, Roshini S. Abraham, Megan Anderson, Yanlei Gu, Atsushi Komano, Hye Sun Kuehn, Jyothi Padiadpu, Siqi Zhao, Sergio D. Rosenzweig, Roxane Tussiwand, W J Leonard, Stefania Pittaluga, Mark Raffeld, Danielle E. Arnold, Andrea Lisco	2025	0
3	Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells Immunity ·Wei Bu, Ashish Kumar, Shao Feng Xuan, C Schyma, Kennichi Dowdell, Shu Zhang, 乐妍, Kelly Morrow-Baez, Tammy Krogmann, Yanmei Wang, Stefania Pittaluga, Joseph Marcotrigiano, Jeffrey I. Cohen	2024	15
4	Peripheral T‐cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK‐negative British Journal of Haematology ·Karthik A. Ganapathi, Alina Nicolae, Caoimhe Egan, Huimin Geng, Liqiang Xi, Svetlana Pack, Helen Van Zante, Mark Raffeld, Elaine S. Jaffe, Stefania Pittaluga	2024	5
5	Abstract PO-008: Phase I/II study of VIP152 (enitociclib), venetoclax, and prednisone (VVIP) in relapsed/refractory (R/R) lymphoid malignancies Blood Cancer Discovery ·Christopher Melani, Max J. Gordon, M R. HAYDEN, Stefania Pittaluga, Li Chenmeng, Jagan Muppidi, James D. Phelan, Svetlana Pack, Amynah Pradhan, Candis Morrison, Rati Nofrianti, مریم آجورلو, Amy J. Johnson, Melanie M. Frigault, Ahmed Hamdy, Mark Roschewski, Louis M. Staudt, Wyndham H. Wilson	2024	0
6	Subcutaneous panniculitis-like T-cell lymphoma in two unrelated individuals with BENTA disease Clinical Immunology ·Bradly M. Bauman, Batsukh Dorjbal, Stefania Pittaluga, Yu Zhang, Julie E. Niemela, Jennifer Stoddard, Sergio D. Rosenzweig, 石明吉, Gregory M.T. Guilcher, Iwona Auer, Renée Perrier, Anncie Bagge Carlson, Nooria Iqbal, Camille Alba, Gauthaman Sukumar, Clifton L. Dalgard, Vishal Dhankhar, Nicola Wright, Helen C. Su, Andrew L. Snow	2023	4
7	Mepolizumab incompletely suppresses clinical flares in a pilot study of episodic angioedema with eosinophilia Journal of Allergy and Clinical Immunology ·Paneez Khoury, Michelle Makiya, Frithjof Trapp, Göran Djupsund, D. Nicolás Espinoza, Adam Schiffenbauer, Costanza Natali, Charles E. Anderson, Gregory Constantine, Irina Marić, Xiaoping Sun, Stefania Pittaluga, Thomas D. Brown, JeanAnne Ware, Lauren Wetzler, Michael P. Fay, Amy D. Klion	2023	3
8	IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion Clinical Cancer Research ·Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga, Chyi‐Chia Richard Lee, Miloš D. Miljković, Thomas A. Fleisher, Sigrid Dubois, Bonita R. Bryant, Michael Petrus, Liyanage P. Perera, Jennifer L. Hsu, William D. Figg, Cody J. Peer, Joanna H. Shih, Jason L. Yovandich, Stephen P. Creekmore, Mario Roederer, Thomas A. Waldmann	2019	95
9	Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR Blood ·Norihiko Terahara, Mark A. Ahlman, Christopher Melani, Stefania Pittaluga, Kieron Dunleavy, Andrea N. Lucas, Seth M. Steinberg, Elaine S. Jaffe, Wyndham H. Wilson, Mark Roschewski	2019	0
10	Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis Blood ·Christopher Melani, Mark Roschewski, Stefania Pittaluga, Jeffrey I. Cohen, Andrea N. Lucas, Seth M. Steinberg, Elaine S. Jaffe, Wyndham H. Wilson	2018	3
11	Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma Blood ·Nakhle S. Saba, Delong Liu, Sarah E. M. Herman, Chingiz Underbayev, Xin Tian, 幸子矢代, Marc A. Weniger, Martin Skarzynski, Pineda Pena AC, Lorena Fontán, Ari Melnick, Clíona Grant, Mark Roschewski, Alba Navarro, Sı́lvia Beà, Stefania Pittaluga, Kieron Dunleavy, Wyndham H. Wilson, Adrian Wiestner	2016	111
12	Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease Blood ·Thomas S. Uldrick, Mark N. Polizzotto, Karen Aleman, Kathleen M. Wyvill, Vickie Marshall, Denise Whitby, Victoria Wang, Stefania Pittaluga, Deirdre O’Mahony, Seth M. Steinberg, Richard F. Little, Robert Yarchoan	2014	80
13	Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations Blood ·Susan Price, Pamela A. Shaw, Amy E. Seitz, Gyan Joshi, Joie Davis, Julie E. Niemela, Katie Perkins, Ronald L. Hornung, Les Folio, Philip S. Rosenberg, Jennifer M. Puck, Amy P. Hsu, Bernice Lo, Stefania Pittaluga, Elaine S. Jaffe, Thomas A. Fleisher, V. Koneti Rao, Michael J. Lenardo	2014	134
14	B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma Clinical Cancer Research ·Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, James N. Kochenderfer Hit paper breakdown →	2013	492
15	The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma Blood ·Kieron Dunleavy, Richard F. Little, Stefania Pittaluga, Nicole Grant, Alan S. Wayne, Jorge A. Carrasquillo, Seth M. Steinberg, Robert Yarchoan, Elaine S. Jaffe, Wyndham H. Wilson	2010	123
16	Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Blood ·Kieron Dunleavy, Stefania Pittaluga, Myron S. Czuczman, Sandeep S. Davé, George W. Wright, Nicole Grant, Margaret Shovlin, Elaine S. Jaffe, John E. Janik, Louis M. Staudt, Wyndham H. Wilson	2009	371
17	EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies Clinical Cancer Research ·Deirdre O’Mahony, John C. Morris, Maryalice Stetler‐Stevenson, Helen Matthews, Margaret R. Brown, Thomas A. Fleisher, Stefania Pittaluga, Mark Raffeld, Paul S. Albert, Dirk J. Reitsma, Karen Kaucic, Luz Hammershaimb, Thomas A. Waldmann, John E. Janik	2009	35
18	Large-Scale Profiling of Archival Lymph Nodes Reveals Pervasive Remodeling of the Follicular Lymphoma Methylome Cancer Research ·Jonathan Keith Killian, Sven Bilke, Sean Davis, Robert L. Walker, M. Scott Killian, Erich Jaeger, Yidong Chen, Jason Hipp, Stefania Pittaluga, Mark Raffeld, Robert Cornelison, William I. Smith, Marina Bibikova, Jian-Bing Fan, Michael R. Emmert‐Buck, Elaine S. Jaffe, Paul S. Meltzer	2009	36
19	Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers Journal of Clinical Oncology ·Wyndham H. Wilson, Kieron Dunleavy, Stefania Pittaluga, Upendra P. Hegde, Nicole Grant, Seth M. Steinberg, Mark Raffeld, Martin Gutierrez, Bruce A. Chabner, Louis M. Staudt, Elaine S. Jaffe, John E. Janik	2008	217
20	Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone Blood ·Andrew L. Feldman, Daniel A. Arber, Stefania Pittaluga, Antonio Martı́nez, Jerome S. Burke, Mark Raffeld, Mireia Camós, Roger A. Warnke, Elaine S. Jaffe	2008	221

About Stefania Pittaluga

Stefania Pittaluga is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Dermatology, having authored 399 papers that have together received 19.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (244 papers), Viral-associated cancers and disorders (125 papers), Chronic Lymphocytic Leukemia Research (111 papers), CNS Lymphoma Diagnosis and Treatment (51 papers), Immune Cell Function and Interaction (46 papers), CAR-T cell therapy research (34 papers), Cutaneous lymphoproliferative disorders research (34 papers) and Histiocytic Disorders and Treatments (25 papers). The work is most often cited by research in Pathology and Forensic Medicine (10.0k citations), Genetics (4.6k citations), Oncology (9.8k citations), Immunology (4.6k citations) and Neurology (2.8k citations). Stefania Pittaluga has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Elaine S. Jaffe, Mark Raffeld, Wyndham H. Wilson, Seth M. Steinberg, Kieron Dunleavy, Louis M. Staudt, Girish Venkataraman, Richard F. Little, Liqiang Xi and Robert Yarchoan. Their work appears in journals such as Blood, The American Journal of Surgical Pathology, Journal of Clinical Oncology, Haematologica and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact